CAS NO: | 732983-37-8 |
包装 | 价格(元) |
100mg | 电议 |
250mg | 电议 |
500mg | 电议 |
生物活性 | BAY 61-3606 is an orally available, ATP-competitive, reversible and highly selectiveSykinhibitor with aKiof 7.5 nM and anIC50of 10 nM[1]. BAY 61-3606 reduces ERK1/2 andAktphosphorylation in neuroblastoma cell[2]. BAY 61-3606 induces a large decrease ofSykphosphorylation in K-rn cell lysates[3]. Bay 61-3606 sensitizes TRAIL-inducedapoptosisby downregulatingMcl-1in breastcancercells[4]. | ||||||||||||||||||||||||
IC50& Target | Ki: 7.5 nM (Syk)[1] | ||||||||||||||||||||||||
体外研究 (In Vitro) | BAY 61-3606 (0.01-10 μM ; 48 hours) significantly reduces the cell viability of SYK-positive SH-SY5Y and SYK-negative SK-N-BE cells in a dose-dependent matter. SH-SY5Y cells expressing high SYK levels are significantly more sensitive to BAY 61-3606 in comparison to SK-N-BEcells expressing very low or no SYK[2]. Cell Viability Assay[2]
Western Blot Analysis[2]
Western Blot Analysis[3]
| ||||||||||||||||||||||||
体内研究 (In Vivo) | Bay 61-3606 (50 mg/kg; administered twice a week for two weeks by intraperitoneal injection) alone leads to more efficacious reductions than that of TNF-related apoptosis-inducing ligand (TRAIL; 10 mg/kg) alone in MCF-7 tumor xenograft-bearing BALB/c nude mice. Bay 61-3606 administered in TRAIL combination significantly reduces the volume of the xenografted tumor[4].
| ||||||||||||||||||||||||
分子量 | 390.40 | ||||||||||||||||||||||||
性状 | Solid | ||||||||||||||||||||||||
Formula | C20H18N6O3 | ||||||||||||||||||||||||
CAS 号 | 732983-37-8 | ||||||||||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||||||||||
储存方式 |
| ||||||||||||||||||||||||
溶解性数据 | In Vitro: DMSO : 5 mg/mL(12.81 mM;ultrasonic and warming and heat to 80℃) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |